| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 27 |
| 1 | MYCOPHENOLATE MOFETIL | 24 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 3 | TACROLIMUS OINTMENT 0.1% | 22 |
| 4 | PREDNISOLONE | 21 |
| 5 | PREDNISOLONE ORAL | 21 |
| 6 | PREDNISOLONE ORAL SOLUTION | 21 |
| 7 | PREDNISONE | 17 |
| 8 | VORICONAZOLE | 14 |
| 9 | RITUXIMAB | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 5 | 0.0016 |
| 1 | CLOFARABINE | 3 | 0.0013 |
| 2 | BELATACEPT | 6 | 0.0013 |
| 3 | ROMIDEPSIN | 2 | 0.0012 |
| 4 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 5 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 6 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 4 | 0.0005 |
| 8 | THIOGUANINE | 1 | 0.0005 |
| 9 | VORICONAZOLE | 14 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 52 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| 2 | Azole Antifungal [EPC] | 22 |
| 3 | Alkylating Drug [EPC] | 17 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 13 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 12 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| 7 | Topoisomerase Inhibitor [EPC] | 8 |
| 8 | Janus Kinase Inhibitor [EPC] | 7 |
| 9 | Kinase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 1 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 2 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | Actinomycin [EPC] | 1 | 0.0005 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |